SIGLEC 8 therapeutics (Johns Hopkins University/Northwestern University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSIGLEC 8 therapeutics (Johns Hopkins University/Northwestern University)
Drug Alias Namecarbohydrate based siglec-8 agonist (Johns Hopkins University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSialic acid-binding Ig-like lectin 8 stimulants
TargetsSialic acid-binding Ig-like lectin 8
Therapy Area/IndicationsInflammationHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins Technology VenturesJohns Hopkins UniversityNorthwestern University
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A